1-16 of 16
Seda S. Tolu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual HDAC and EZH2 Inhibition Primes Mosunetuzumab for the Treatment of Germinal Center-Derived B-Cell Lymphoma

Ted B. Piorczynski, Saagar Jain, Manuel Pazos, II, Yun Kyoung Tiger, Seda S. Tolu, Jennifer E. Amengual
Journal: Blood
Blood (2024) 144 (Supplement 1): 973.
https://doi.org/10.1182/blood-2024-194360
Published: 2024
Journal Articles

Combination JAK Inhibition and Immune Checkpoint Blockade for the Treatment of 9p Amplified Lymphomas

Seda S. Tolu, Ted B. Piorczynski, Manuel Pazos, II, Brian Estrella, Hua-Jay J Cherng, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2024) 144 (Supplement 1): 336.
https://doi.org/10.1182/blood-2024-203382
Published: 2024
Journal Articles

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Matthew Hamby, Brian Egleston, Zachary AK Frosch, Raphael E. Steiner, Ariela Noy, Veronica Carvajal, Seda S. Tolu, Gaston Jean-Louis, Jennifer E. Amengual, Romil Patel, Sairah Ahmed, Timothy Voorhees, Robert Baiocchi, Andres Ramirez-Gamero, Jorge J. Castillo, Emily Hamburger, Christopher Dittus, Imran A. Nizamuddin, Neha Mehta-Shah, Nyein Nyein Thaw Dar, Jose Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Vinod Solipuram, Paul G. Rubinstein, Anthony Ariotti, Gita Suneja, Alexander Vartanov, Charles Milrod, Adam J. Olszewski, Gordon Smilnak, Emily Ayers, Sahaj Desai, Joanna M. Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Vineel Bhatlapenumarthi, Mehdi Hamadani, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 573.
https://doi.org/10.1182/blood-2024-198008
Published: 2024
Journal Articles

Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort

Juan Pablo Alderuccio, Jahanzaib Khwaja, Sunwoo Han, Paola Ghione, Imran A. Nizamuddin, Aditi Saha, Ning Dong, Yucai Wang, Hua-Jay J Cherng, Seda S. Tolu, Nina Wagner-Johnston, Adam J. Olszewski, Natalie Grover, Jean L. Koff, Amrita Desai, Praveen Ramakrishnan Geethakumari, Tamara K Moyo, Jose Sandoval-Sus, Narendranath Epperla, Danielle S Wallace, Manali Kamdar, Alexey Danilov, Han W. Tun, Javier Munoz, Mayur S. Narkhede, Joanna M. Rhodes, Anca Prica, Andrea Kuhnl, Adrian Maraj, Jessica Okosun, Jeffery Smith, Wendy Osborne, Victoria Calvert, Dima el-Sharkawi, Ammar Hilali, Graham P. Collins, Kim Linton, Nagah Elmusharaf, Anna Santarsieri, Farheen Karim, Thomas Ollila, Sarah Monick, Iris Margalit Trutzer, Nilanjan Ghosh, Jones Can, Amy Ayers, Jacopo Calabrese De Feo, John Sharp, Rachel Treitman, Avyakta Kallam, Izel Okcu, Vismay Deshani, Firas Baidoun, Chathuri Abeyakoon, William Hann, Aisling Barrett, Brad Kahl, Julio C. Chavez, Kate Cwynarski
Journal: Blood
Blood (2024) 144 (Supplement 1): 571.
https://doi.org/10.1182/blood-2024-199781
Published: 2024
Journal Articles

Diagnostic Utility of the 18 f-FDG PET/CT Scan in Solid Organ Transplant Patients with EBV Reactivation at Risk for Post-Transplant Lymphoproliferative Disorder

Hua-Jay J Cherng, Rebecca Scalabrino, Patrick Gould, Alexander Sanjurjo, Brian Cuzzo, Saagar Jain, Hong Y Ma, Maegan Ford, Evelyn H. Orlando, Dorine De Jong, Manuela A Orjuela, Andrew H. Lipsky, Seda S. Tolu, Barbara Pro, Jennifer E. Amengual, Kathleen M Capaccione
Journal: Blood
Blood (2024) 144 (Supplement 1): 3077.
https://doi.org/10.1182/blood-2024-194265
Published: 2024
Journal Articles

Etctn P10500: Phase 1 Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma

Jennifer E. Amengual, Aung M. Tun, Ted B. Piorczynski, Yun Kyoung Tiger, Victor Yazbeck, Hua-Jay J Cherng, Seda S. Tolu, Barbara Pro, Diane Durecki, Jan Beumer, Neil Kelleher, Naomi Sender, Sarah Sta Ana, Anxhela Kalia, Beatriz Raposo Corradini, Yu Shyr, Patricia LoRusso, Lorraine Pelosof, Richard Piekarz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3112.
https://doi.org/10.1182/blood-2024-199650
Published: 2024
Journal Articles

Association between Food Insecurity, Financial Toxicity, and Healthcare Utilization in Patients with Lymphoma

Kishan A Bhatt, David M. DeStephano, Rhea K Khurana, Claire Sathe, Seda S. Tolu, Hua-Jay J. Cherng, Jennifer E. Amengual, Barbara Pro, Dawn L Hershman, Justine M. Kahn, Melissa P Beauchemin
Journal: Blood
Blood (2024) 144 (Supplement 1): 5042.
https://doi.org/10.1182/blood-2024-210508
Published: 2024
Journal Articles

First-in-Class HAT Activator (YF2) Combined with JAK/STAT Inhibitor (ruxolitinib) Unveils Potential Novel Treatment Approach for HDAC Inhibitor-Resistant CTCL

Manuel Pazos, II, Brian Estrella, Ted B. Piorczynski, Seda S. Tolu, Wenxuan Huang, Yun Kyoung Ryu, Jennifer E Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 4184.
https://doi.org/10.1182/blood-2023-186639
Published: 2023
Journal Articles

JAK1/2 Inhibition Modulates Key Markers of Lymphomagenesis in 9p24.1 Amplified Lymphoma, Priming for Enhanced Antigenicity

Seda S. Tolu, Ted B. Piorczynski, Manuel Pazos, II, Brian Estrella, Wenxuan Huang, Yun Kyoung Ryu, Hua-Jay J. Cherng, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 6118.
https://doi.org/10.1182/blood-2023-180875
Published: 2023
Journal Articles

Outcomes of Contemporary Novel Agent and Stem Cell Transplantation in Relapsed/Refractory PTCL

Seda S. Tolu, Caitlin Gribbin, Madhav R Seshadri, Zhengming Chen, Evelyn Orlando, Justin Grenet, Rajbir Toor, Alexander Sanjurjo, Adrienne A. Phillips, Tsiporah B. Shore, Peter Martin, John P. Leonard, Barbara Pro, Jennifer E. Amengual, Jia Ruan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1698.
https://doi.org/10.1182/blood-2023-178231
Published: 2023
Journal Articles

Outcomes in Minorities with PTCL By Clinical Trial Enrollment

Seda S. Tolu, Alexander Sanjurjo, David Destephano, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 4431.
https://doi.org/10.1182/blood-2023-177722
Published: 2023
Journal Articles

Combination Epigenetic Therapy Using YF2, a First-in-Class Histone Acetyltransferase Activator, Restores Immunogenicity in Diffuse Large B-Cell Lymphoma

Ted B. Piorczynski, Yun Kyoung Ryu, Manuel Pazos, II, Wenxuan Huang, Seda S. Tolu, Brian Estrella, Jennifer E Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2023-179271
Published: 2023
Journal Articles

Queen's gambit: response-adapted win in CAYA with cHL

Clinical Trials & Observations
Seda S. Tolu, Jennifer E. Amengual
Journal: Blood
Blood (2023) 141 (17): 2037–2038.
https://doi.org/10.1182/blood.2022019339
Published: 2023
Journal Articles

High Hemoglobin F in Sickle Cell Disease: Waning Protection with Age

Seda S. Tolu, MD, Morayma Reyes Gil, MD PhD, Ugochi Olivia Ogu, MD, Jui Choudhuri, MD, Roger Fecher, MD, Gracy Sebastian, NP, Caterina P. Minniti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3576.
https://doi.org/10.1182/blood-2019-122387
Published: 2019
Journal Articles

Common Myeloid Progenitors As Biomarkers of Hbf Response to Hydroxyurea in Sickle Cell Disease

Caterina P. Minniti, MD, Seda S. Tolu, MD, Kai Wang, PhD, Zi Yan, Andrew Crouch, Gracy Sebastian, NP, Mark Chaitowitz, MD, Evan Schwechter, MD, Joan Uehlinger, MD, Deepa Manwani, MD, Eric Fornari, MD, Eric E. Bouhassira, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4827.
https://doi.org/10.1182/blood-2019-131466
Published: 2019
Journal Articles

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

Seda S. Tolu, MD, Kai Wang, PhD, Zi Yan, Andrew Crouch, Gracy Sebastian, NP, Mark Chaitowitz, MD, Eric Fornari, MD, Evan Schwechter, MD, Joan Uehlinger, MD, Deepa Manwani, MD, Caterina P. Minniti, MD, Eric E. Bouhassira, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 985.
https://doi.org/10.1182/blood-2019-131648
Published: 2019